Health
Researchers develop new gene therapy vector for blood disorders – The Science Board
Researchers at Children’s Hospital of Philadelphia have developed a new gene therapy vector for blood disorders that is safer and more effective than those currently…
The new vector is an engineered lentivirus that minimizes the risk of toxic side effects in disorders such as sickle cell disease and beta-thalassemia. Typically, lentiviral vectors include a truncated version of intron 2 that does not code for proteins. But the team hypothesized that inclusion of a full-length intron, in addition to other genomic elements, could promote a uniform expression of the beta-globin gene and enhance functional hemoglobin. Based on this, they generated five vectors by…
-
General22 hours agoMan dies in daylight shooting in Sydney’s north-west
-
General23 hours agoMurder trial begins for man accused of killing and burning David Collisson near Mudgee
-
Noosa News23 hours agoGlencore receives taxpayer bailout to save Mt Isa mining jobs
-
General16 hours agoNewsCorp executive warns AI firms are asking Australia to ‘surrender our stories’